|
|
 |
Innovations in HIV Therapy
ISSUE: NOVEMBER, 2008
Last year, we were reveling in
hope and excitement because
unprecedented numbers of
promising new anti-HIV agents
entered clinical trials. We also saw
4 new potent drugs become
available, with 2 emerging from
entirely new drug classes (maraviroc
[Selzentry, Pfizer]; raltegravir
[Isentress, Merck]).
read more |
|
Recent Advances in
MRSA
Surveillance
Detection
ISSUE: NOVEMBER, 2008
Methicillin-resistant
Staphylococcus
aureus (MRSA) is
a common cause of health
care–associated infections,
and its prevalence
continues to increase
worldwide.1,2 MRSA
infections are a major
cause of morbidity and
mortality, and they are
associated with excess
hospital costs.3-5
read more |
Misconceptions About MRSA
ISSUE: NOVEMBER, 2008
As an infectious diseases specialist, I am concerned
about the lack of understanding of how
to best deal with methicillin-resistant Staphylococcus
aureus (MRSA) within the medical
community and the misconceptions about these bacteria
perpetuated not only by the media but also by credible
medical organizations and physicians.
read more |
Advances in the Prevention of Health Care–Associated Infections
ISSUE: NOVEMBER, 2008
Health care–associated infections
(HAIs) are an important cause of
morbidity and mortality and place a
significant economic burden on the health
care system.1,2 An estimated 1.7 million
HAIs, or 4.5 infections per 100 hospital
admissions, occurred in the United States in
2002, resulting in nearly 100,000 deaths.3
read more |
|
|
|
|
|
VOLUME 1 • 2009 |
|
|
| |
|
